MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
20.06
+1.01 (5.30%)
At close: Jul 21, 2026, 4:00 PM EDT
20.07
+0.01 (0.05%)
After-hours: Jul 21, 2026, 7:34 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $1.66 billion as of July 21, 2026. Its market cap has decreased by -50.82% in one year.
Market Cap
1.66B
Enterprise Value
1.40B
1-Year Change
-50.82%
Ranking
Category
Stock Price
$20.06
ChartMarket Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.66B, an increase of 45,959.71%. That is a compound annual growth rate of 298.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 1.66B | 76.17% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 1.73B |
| AnaptysBio | 1.72B |
| MapLight Therapeutics | 1.72B |
| Ascentage Pharma Group International | 1.71B |
| Fortrea Holdings | 1.68B |
| Innoviva | 1.60B |
| Vir Biotechnology | 1.59B |
| Intellia Therapeutics | 1.59B |